Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis
Dr. Vatakis, appointed as Medical Director, brings decades of clinical trial leadership, advancing Synbio’s credibility and the integrity of its upcoming feasibility trial New York City, October 22, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is proud to announce the appointment […]
Synbio International Inc. Strengthens Strategic Alliance with FacialDx Inc. through Share Purchase and Warrant Agreements
New York, NY, October 08, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is pleased to announce the execution of a Share Purchase Agreement and Warrant Agreement (SPA) with FacialDx, Inc., further strengthening the strategic partnership established under the Clinical Trial License […]
Synbio International Inc. Expands Board and Strengthens Leadership with Appointment of Chief Financial Officer Ms. Desiree Cain, CPA, MBA
Strategic appointment underscores Synbio’s commitment to financial excellence, governance, and shareholder value NEW YORK, Oct. 02, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Synbio International Inc. (OTC: SYIN) (“Synbio” or the “Company”) is pleased to announce the appointment of Ms. Desiree Cain, CPA, MBA as Chief Financial Officer and Member […]